Dihydromyricetin, often abbreviated DHM, is a plant-derived flavonoid with genuinely interesting biological activity, but a body of evidence that leans heavily on animal and cell studies rather than human trials. Most people encounter it as the active ingredient in “anti-hangover” supplements, and that reputation is not entirely unfounded: rodent research shows DHM can speed alcohol metabolism and counteract some of alcohol’s effects on the brain. Beyond alcohol, preclinical work suggests benefits for liver health, blood sugar regulation, inflammation, and even brain protection. The catch is that human data remain thin, and DHM’s poor absorption by the body limits how much of a capsule actually reaches your bloodstream.
Where DHM Comes From
DHM is found in highest concentrations in the leaves of Ampelopsis grossedentata, a climbing vine in the grape family native to southern China and Southeast Asia. The plant has been brewed into a beverage known as vine tea or “tengcha” for centuries. DHM can make up a remarkably large share of the dried leaf, which is unusual for a single flavonoid in a plant source. Researchers have explored multiple extraction methods to pull DHM from the leaves efficiently, from simple water extraction to ultrasonic and microwave-assisted techniques.1Journal of AOAC INTERNATIONAL. Comparison of Refluxing, Ultrasonic- and Microwave-Assisted Extraction of Dihydromyricetin from Ampelopsis grossedentata The compound also appears in smaller amounts in Hovenia dulcis (the Japanese raisin tree), which has its own long history of use for alcohol-related ailments in East Asian traditional medicine.
The Alcohol Connection
DHM’s popularity in the supplement market rests almost entirely on its relationship with alcohol. The research here spans two distinct mechanisms: how DHM interacts with alcohol metabolism in the liver, and how it affects the brain receptors that alcohol targets.
On the metabolism side, one study in mice found that DHM boosted the expression of ethanol-metabolizing enzymes and lowered concentrations of both ethanol and acetaldehyde, the toxic intermediate your body produces when breaking down alcohol.2PubMed Central. Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism A cell study similarly found that DHM could increase the activity of both alcohol dehydrogenase and aldehyde dehydrogenase, the two key enzymes in the alcohol breakdown chain.3PubMed. Effects of Hovenia dulcis fruit and peduncle extract on alcohol metabolism However, the picture is not unanimous. A separate study found that DHM did not influence alcohol dehydrogenase activity or expression at all.4PubMed Central. Does dihydromyricetin impact on alcohol metabolism The disagreement likely reflects differences in experimental models, doses, and timing, but it means the metabolic story is still being sorted out.
The brain-level mechanism may be more consequential. A widely cited study published in the Journal of Neuroscience showed that DHM acts on the same receptor system alcohol does: the GABA-A receptors. In rats, DHM counteracted alcohol’s ability to amplify GABA-A receptor signaling, effectively reducing signs of intoxication. Rats given DHM after heavy alcohol exposure showed less motor impairment and reduced signs of withdrawal. The effect was blocked by flumazenil, a drug used clinically to reverse sedation from benzodiazepines, which strongly suggests DHM is working through the benzodiazepine binding site on GABA-A receptors.5PubMed Central. Dihydromyricetin as a novel anti-alcohol intoxication medication This is not a trivial finding. It means DHM may do more than help you metabolize alcohol faster; it may partially block the neurological effects of alcohol while it is still in your system.6PubMed Central. Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors
What the Human Evidence Actually Shows
Here is where expectations need to be tempered. A 2025 systematic review looking specifically at DHM and alcohol-related conditions found that clinical evidence was limited to two small trials, and those trials used Hovenia dulcis extracts rather than isolated DHM. The extracts reduced hangover severity and some inflammatory markers, but because they contained multiple active compounds, the contribution of DHM alone could not be separated out.7PubMed Central. Therapeutic Effects of Dihydromyricetin on Wholly Alcohol-Attributed Conditions: A Systematic Review That is a meaningful gap. Much of what gets said about DHM’s hangover benefits extrapolates from rodent studies to human supplement capsules, skipping the part where someone actually tests it rigorously in people.
One observational cohort study did evaluate a multi-ingredient supplement containing DHM and L-cysteine against alcohol-only nights. Participants reported statistically significant improvements in mental clarity, physical well-being, and energy the morning after drinking, with the supplement closing roughly 50 to 80 percent of the gap between alcohol-impaired and sober mornings across different measures.8PubMed Central. Decentralized Assessment of a Dihydromyricetin- and L-Cysteine-Based Multi-Ingredient Dietary Supplement on Post-Alcohol Recovery: An Observational Cohort Study The limitations are obvious: observational design, subjective outcomes, a multi-ingredient formula. But it is one of the few data points involving actual humans drinking actual alcohol and reporting how they felt afterward.
A more clinically rigorous trial tested a DHM-containing dietary supplement in adults with metabolic dysfunction-associated steatotic liver disease (the condition formerly called nonalcoholic fatty liver disease). Over 12 months, patients receiving the supplement, which contained 300 mg/day of DHM alongside vitamins C, E, and choline, achieved notably higher rates of liver enzyme normalization compared to placebo: 35 percent versus 5 percent. The supplement group also saw declines in blood glucose, glycated hemoglobin, and liver stiffness measurements.9PubMed Central. Dietary supplement based on dihydromyricetin in metabolic dysfunction-associated steatotic liver disease: a double-blind, placebo-controlled, randomized clinical trial Because this was a double-blind, placebo-controlled trial, it carries more weight than most DHM evidence, though the multi-ingredient design again makes it hard to attribute the results to DHM alone.
Liver Protection Beyond Alcohol
The liver is probably the organ with the strongest preclinical case for DHM. In animal models of both alcohol-induced and chemical-induced liver injury, DHM has been shown to reduce liver cell death and fat accumulation while promoting liver regeneration.10PubMed. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease In rats fed a high-fat diet to induce fatty liver, DHM treatment reversed fat buildup and improved insulin sensitivity by activating cellular energy-sensing pathways that trigger autophagy, the process cells use to clean out damaged components.11PubMed Central. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway
The consistent theme across these studies is that DHM seems to help the liver handle metabolic stress, whether that stress comes from alcohol, a high-fat diet, or toxic exposure. That is a reasonable biological story: flavonoids as a class tend to have antioxidant and anti-inflammatory effects, and the liver, as the body’s primary detoxification organ, is positioned to benefit most directly from those properties.
Blood Sugar and Metabolic Health
Several animal studies point to DHM as a potential tool for managing blood sugar. In db/db mice, a widely used model of type 2 diabetes, oral DHM at two different doses reduced fasting blood glucose, insulin levels, and glycated hemoglobin. It also lowered body weight and improved blood lipid profiles while decreasing abdominal fat. The mechanism appeared to involve improving how cells respond to insulin signaling.12PubMed Central. Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice
A study in Zucker diabetic fatty rats compared DHM directly to rosiglitazone, a prescription diabetes drug. DHM delayed the onset of high blood sugar by about four weeks, preserved insulin-producing cells in the pancreas, and improved blood lipid levels more robustly than rosiglitazone. The standout finding was that DHM achieved these effects without causing the weight gain that rosiglitazone is notorious for. Rosiglitazone-treated rats gained significantly more weight and accumulated more fat, while DHM actually decreased fat buildup in both the liver and fat tissue.13PubMed. Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats These are animal results, and rat metabolism is not human metabolism, but the weight-neutral blood sugar improvement is the kind of profile that makes researchers pay attention.
Anti-Inflammatory and Antioxidant Effects
Like many flavonoids, DHM acts as both an antioxidant and an anti-inflammatory agent. What sets it apart somewhat is the apparent potency of these effects in certain models. In a rheumatoid arthritis animal model, DHM significantly suppressed key inflammatory signals including IL-1β, IL-6, TNF-α, and COX-2, the same enzyme targeted by common anti-inflammatory drugs like ibuprofen. The mechanism ran through activation of the Nrf2 pathway, a master regulator of antioxidant defenses. When researchers blocked Nrf2 with an inhibitor, DHM’s anti-inflammatory benefits disappeared, confirming Nrf2 as a critical link.14PubMed. Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model The same Nrf2-activating property has been observed in other contexts, including wound healing and tissue protection from oxidative damage.15PubMed Central. Dihydromyricetin regulates KEAP1‐Nrf2 pathways to enhance the survival of ischemic flap
Brain Protection
Beyond its interaction with GABA-A receptors in the context of alcohol, DHM has been investigated for neuroprotective properties. In an Alzheimer’s disease rat model, treatment with DHM at 100 or 200 mg/kg reversed cognitive decline, reduced brain inflammation, and decreased death of hippocampal cells. The higher dose produced more pronounced improvements. The mechanism involved activating AMPK/SIRT1 signaling, an energy-sensing pathway that cells use to manage stress and inflammation.16PubMed Central. Protective role of Dihydromyricetin in Alzheimer’s disease rat model associated with activating AMPK/SIRT1 signaling pathway This is early-stage, single-model evidence and should not be interpreted as suggesting DHM treats or prevents Alzheimer’s in people. But the direction of the findings is consistent with the broader anti-inflammatory and antioxidant profile.
The Bioavailability Problem
One of DHM’s most significant practical limitations is how poorly the body absorbs it. When given orally to rats, DHM reached peak blood concentrations of only about 22 ng/mL, with a half-life of roughly 3.7 hours. The absolute oral bioavailability was calculated at just 4 percent, meaning 96 percent of the dose never made it into the bloodstream in a usable form.17PubMed Central. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study This reflects a combination of low water solubility and poor ability to cross cell membranes, both of which limit absorption in the gut.18PubMed Central. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability
Researchers are actively trying to solve this. A liposome formulation using ginsenoside as a stabilizer boosted DHM’s water solubility more than tenfold and roughly doubled intestinal absorption rates compared to free DHM.19Food Bioscience. Nanoliposome strategy for improving bioavailability and anti-acute alcoholic effects of dihydromyricetin through ginsenoside incorporation A separate approach using biodegradable nanoparticles doubled the area under the curve (a measure of total drug exposure over time) and extended DHM’s half-life by about 46 percent compared to plain DHM.20PLOS ONE. Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium These advanced delivery systems are not yet widely available in consumer supplements, which mostly contain standard DHM powder. This matters because those impressive effects seen in cell and animal studies often use concentrations or routes of administration (like intravenous injection) that capsules swallowed on an empty stomach simply cannot replicate.
Safety and Side Effects
Based on available preclinical data, DHM appears to have low acute toxicity. Rodent studies using relatively high doses have reported no obvious adverse effects on liver or kidney function in short-term studies.21PubMed Central. Pharmacological effects of dihydromyricetin in preclinical models of NAFLD: a systematic review and meta-analysis stratified by dose and duration The compound has a long history of use in vine tea in southern China, which provides some indirect reassurance about safety at dietary levels, though traditional-use history does not substitute for controlled safety studies.
The important caveats are about what we do not know rather than what we do. Comprehensive data on long-term administration, reproductive toxicity, and drug interactions in humans are essentially missing.21PubMed Central. Pharmacological effects of dihydromyricetin in preclinical models of NAFLD: a systematic review and meta-analysis stratified by dose and duration The absence of reported harm is not the same as demonstrated safety, especially for someone taking DHM daily for months. If you are pregnant, nursing, or managing a chronic condition, there is simply no human safety data to guide you.
Drug Interactions Worth Knowing About
This is an area that deserves more attention than most DHM supplement labels give it. In lab studies, DHM inhibited the activity of CYP3A4, the liver enzyme responsible for metabolizing an estimated half of all prescription drugs. It also inhibited CYP2D6 and CYP2E1. For CYP3A4, DHM acted as a time-dependent inhibitor, meaning its blocking effect grows the longer it is present.22PubMed Central. In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes In theory, this could increase the blood levels of medications processed by these enzymes, potentially amplifying their effects or side effects. Common drugs metabolized by CYP3A4 include many statins, some blood pressure medications, certain antidepressants, and immunosuppressants.
The picture is not entirely consistent across studies, though. A separate investigation found that DHM and its sulfate metabolites exerted only minor inhibitory effects on CYP3A4, CYP2C9, and CYP2C19.23PubMed Central. Interaction of myricetin, ampelopsin (dihydromyricetin), and their sulfate metabolites with serum albumin, cytochrome P450 (CYP2C9, 2C19, and 3A4) enzymes, and organic anion-transporting polypeptides (OATP1B1 and OATP2B1) Another study found that DHM did not significantly interfere with the metabolic activity of certain CYP1A enzymes or CYP2B1.24Neuroendocrinology Letters. Role of dihydromyricetin in cytochrome P450-mediated metabolism and carcinogen activation The discrepancies likely come from differences in concentrations tested and whether the studies looked at the parent compound or its metabolites. Until clinical interaction studies are done in humans, caution is reasonable if you take prescription medications regularly. Mention your DHM use to your prescriber, particularly if you are on drugs with a narrow therapeutic window.
Cancer Research
DHM has shown activity against cancer cells in laboratory settings, though this is firmly in the realm of basic research rather than anything approaching clinical application. In ovarian cancer cells, DHM inhibited proliferation and triggered cell death. More intriguingly, it sensitized drug-resistant ovarian cancer cells to paclitaxel and doxorubicin, two widely used chemotherapy agents, by suppressing a protein called survivin that helps cancer cells evade death signals.25PubMed Central. Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin
A study in liver cancer cells found a similarly interesting pattern: DHM combined with a chemotherapy drug produced a synergistic effect in killing cancer cells, while actually protecting normal liver cells from the chemotherapy’s damage.26PLOS ONE. Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells That dual behavior, amplifying damage in cancer cells while shielding healthy ones, is the kind of selectivity drug developers actively seek. But cell studies showing cancer-killing effects are extremely common in natural-product research, and the vast majority never translate to treatments that work in living people. Treat this as a reason to watch the field, not a reason to take DHM for cancer prevention.
Skin Protection and Antimicrobial Uses
A few research threads sit further from the mainstream DHM conversation but hint at broader applications. In a mouse study, topical DHM reduced sunburn, redness, and blistering from UV-B radiation. When combined with ellagic acid, the protective effect was stronger than either compound alone, with the combination preventing damage to skin cell structures and nuclei.27PubMed. Consumption of ellagic acid and dihydromyricetin synergistically protects against UV-B induced photoaging, possibly by activating both TGF-β1 and wnt signaling pathways DHM appeared to work partly by activating signaling pathways involved in tissue repair and partly by reducing oxidative stress. Whether this will eventually show up in consumer sunscreen or anti-aging products remains to be seen, but the cosmetic industry has been paying attention to flavonoid photoprotection for years.
DHM also shows broad antibacterial activity. Researchers have demonstrated it can inhibit foodborne bacteria and spoilage organisms in aquatic products, with discussion of its potential as a natural preservative to replace synthetic ones in the food industry.28PubMed Central. Antibacterial Activity and Mode of Action of Dihydromyricetin from Ampelopsis grossedentata Leaves against Food-Borne Bacteria The mechanism involves disrupting bacterial cell membrane function and interfering with metabolic processes.29Hindawi. Antibacterial Effect of Dihydromyricetin on Specific Spoilage Organisms of Hybrid Grouper This line of research has more to do with food science than personal health, but it underscores that DHM’s biological effects extend well beyond the “hangover pill” framing most consumers encounter.
What Supplements Actually Deliver
If you are shopping for a DHM supplement, you will find doses typically ranging from 300 mg to 600 mg per capsule, sometimes bundled with other ingredients like N-acetyl cysteine, B vitamins, or milk thistle extract. The evidence does not point to a well-established optimal dose for humans, because dose-finding clinical trials have not been done for most of the conditions DHM is marketed for. The 300 mg/day dose used in the liver disease clinical trial described earlier is one of the few human reference points that exists, and even that was part of a multi-ingredient supplement.
Given the roughly 4 percent bioavailability seen in rats, what reaches your bloodstream from a standard capsule is a small fraction of what you swallow. Some supplement makers now market “enhanced bioavailability” versions, though most consumer products have not been independently tested to verify such claims. Taking DHM with food may or may not improve absorption; the data on this is thin. What you can say with reasonable confidence is that the doses used in many of the animal studies, when adjusted for body weight differences, are often substantially higher than what a typical one- or two-capsule supplement provides.
DHM is sold as a dietary supplement in most markets, not as a pharmaceutical. In the United States, that means it does not require FDA approval before sale, and the manufacturer is responsible for ensuring safety and accurate labeling. Purity and dose accuracy can vary between brands and batches. If you choose to try it, selecting a product from a company that provides third-party testing certificates is one of the few quality filters available to consumers.